Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Australia & New Zealand Spinal Implants and Devices Market by Product Type (SPINAL FUSION DEVICES, NON-FUSION/MOTION PRESERVATION DEVICES, VERTEBRAL COMPRESSION FRACTURE DEVICES, SPINE BONE STIMULATORS, SPINE BIOLOGICS) and by Surgery (OPEN SPINE SURGERY, MINIMALLY INVASIVE SPINE SURGERY): Global Opportunity Analysis and Industry Forecast, 2023-2032

A04502

Pages: NA

Charts: NA

Tables: NA

 Key Market Segments

  • By Product Type
    • SPINAL FUSION DEVICES
    • NON-FUSION/MOTION PRESERVATION DEVICES
    • VERTEBRAL COMPRESSION FRACTURE DEVICES
    • SPINE BONE STIMULATORS
    • SPINE BIOLOGICS
  • By Surgery
    • OPEN SPINE SURGERY
    • MINIMALLY INVASIVE SPINE SURGERY
  • By Region
    • Asia-Pacific
      • Australia
      • New Zealand

 
Key Market Players

  • , Orthofix International N.V
  • Stryker Corporation,
  • , Johnson & Johnson (DePuy Synthes),
  • , Medtronic plc
  • Nuvasive, Inc
  • , B Braun Melsungen AG
  • Zimmer Biomet Holdings, Inc
  • Alphatec Holdings, Inc
  • Globus Medical, Inc
  • Exactech, Inc

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. SPINAL FUSION DEVICES

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. NON-FUSION/MOTION PRESERVATION DEVICES

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. VERTEBRAL COMPRESSION FRACTURE DEVICES

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. SPINE BONE STIMULATORS

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. SPINE BIOLOGICS

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET, BY SURGERY

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Surgery

    • 5.2. OPEN SPINE SURGERY

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. MINIMALLY INVASIVE SPINE SURGERY

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product Type

      • 6.2.3. Market Size and Forecast, By Surgery

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S.

        • 6.2.5.1 Market size and forecast, product type

        • 6.2.5.2 Market size and forecast, surgery

      • 6.2.6. Canada

        • 6.2.6.1 Market size and forecast, product type

        • 6.2.6.2 Market size and forecast, surgery

      • 6.2.7. Mexico

        • 6.2.7.1 Market size and forecast, product type

        • 6.2.7.2 Market size and forecast, surgery

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product Type

      • 6.3.3. Market Size and Forecast, By Surgery

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France

        • 6.3.5.1 Market size and forecast, product type

        • 6.3.5.2 Market size and forecast, surgery

      • 6.3.6. Germany

        • 6.3.6.1 Market size and forecast, product type

        • 6.3.6.2 Market size and forecast, surgery

      • 6.3.7. Italy

        • 6.3.7.1 Market size and forecast, product type

        • 6.3.7.2 Market size and forecast, surgery

      • 6.3.8. Spain

        • 6.3.8.1 Market size and forecast, product type

        • 6.3.8.2 Market size and forecast, surgery

      • 6.3.9. UK

        • 6.3.9.1 Market size and forecast, product type

        • 6.3.9.2 Market size and forecast, surgery

      • 6.3.10. Russia

        • 6.3.10.1 Market size and forecast, product type

        • 6.3.10.2 Market size and forecast, surgery

      • 6.3.11. Rest Of Europe

        • 6.3.11.1 Market size and forecast, product type

        • 6.3.11.2 Market size and forecast, surgery

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product Type

      • 6.4.3. Market Size and Forecast, By Surgery

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China

        • 6.4.5.1 Market size and forecast, product type

        • 6.4.5.2 Market size and forecast, surgery

      • 6.4.6. Japan

        • 6.4.6.1 Market size and forecast, product type

        • 6.4.6.2 Market size and forecast, surgery

      • 6.4.7. India

        • 6.4.7.1 Market size and forecast, product type

        • 6.4.7.2 Market size and forecast, surgery

      • 6.4.8. South Korea

        • 6.4.8.1 Market size and forecast, product type

        • 6.4.8.2 Market size and forecast, surgery

      • 6.4.9. Australia

        • 6.4.9.1 Market size and forecast, product type

        • 6.4.9.2 Market size and forecast, surgery

      • 6.4.10. Thailand

        • 6.4.10.1 Market size and forecast, product type

        • 6.4.10.2 Market size and forecast, surgery

      • 6.4.11. Malaysia

        • 6.4.11.1 Market size and forecast, product type

        • 6.4.11.2 Market size and forecast, surgery

      • 6.4.12. Indonesia

        • 6.4.12.1 Market size and forecast, product type

        • 6.4.12.2 Market size and forecast, surgery

      • 6.4.13. Rest of Asia Pacific

        • 6.4.13.1 Market size and forecast, product type

        • 6.4.13.2 Market size and forecast, surgery

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product Type

      • 6.5.3. Market Size and Forecast, By Surgery

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil

        • 6.5.5.1 Market size and forecast, product type

        • 6.5.5.2 Market size and forecast, surgery

      • 6.5.6. South Africa

        • 6.5.6.1 Market size and forecast, product type

        • 6.5.6.2 Market size and forecast, surgery

      • 6.5.7. Saudi Arabia

        • 6.5.7.1 Market size and forecast, product type

        • 6.5.7.2 Market size and forecast, surgery

      • 6.5.8. UAE

        • 6.5.8.1 Market size and forecast, product type

        • 6.5.8.2 Market size and forecast, surgery

      • 6.5.9. Argentina

        • 6.5.9.1 Market size and forecast, product type

        • 6.5.9.2 Market size and forecast, surgery

      • 6.5.10. Rest of LAMEA

        • 6.5.10.1 Market size and forecast, product type

        • 6.5.10.2 Market size and forecast, surgery

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Alphatec Holdings, Inc

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. , B Braun Melsungen AG

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Exactech, Inc

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. , Johnson And Johnson (DePuy Synthes),

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Globus Medical, Inc

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. , Medtronic Plc

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Nuvasive, Inc

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. , Orthofix International N.V

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Stryker Corporation,

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Zimmer Biomet Holdings, Inc

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET FOR SPINAL FUSION DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET FOR NON-FUSION/MOTION PRESERVATION DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET FOR VERTEBRAL COMPRESSION FRACTURE DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET FOR SPINE BONE STIMULATORS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET FOR SPINE BIOLOGICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 8. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET FOR OPEN SPINE SURGERY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET FOR MINIMALLY INVASIVE SPINE SURGERY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 14. U.S. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 15. U.S. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 16. CANADA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 17. CANADA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 18. MEXICO AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 19. MEXICO AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 21. EUROPE AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 22. EUROPE AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 23. FRANCE AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 24. FRANCE AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 25. GERMANY AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 26. GERMANY AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 27. ITALY AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 28. ITALY AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 29. SPAIN AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 30. SPAIN AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 31. UK AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 32. UK AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 33. RUSSIA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 34. RUSSIA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 35. REST OF EUROPE AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 36. REST OF EUROPE AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 37. ASIA-PACIFIC AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 38. ASIA-PACIFIC AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 39. ASIA-PACIFIC AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 40. CHINA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 41. CHINA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 42. JAPAN AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 43. JAPAN AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 44. INDIA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 45. INDIA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 46. SOUTH KOREA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. SOUTH KOREA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 48. AUSTRALIA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 49. AUSTRALIA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 50. THAILAND AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 51. THAILAND AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 52. MALAYSIA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 53. MALAYSIA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 54. INDONESIA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 55. INDONESIA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 58. LAMEA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 59. LAMEA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 60. LAMEA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 61. BRAZIL AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 62. BRAZIL AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 63. SOUTH AFRICA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH AFRICA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 65. SAUDI ARABIA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 66. SAUDI ARABIA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 67. UAE AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 68. UAE AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 69. ARGENTINA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 70. ARGENTINA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 71. REST OF LAMEA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 72. REST OF LAMEA AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES, BY SURGERY, 2022-2032 ($MILLION)
  • TABLE 73. ALPHATEC HOLDINGS, INC: KEY EXECUTIVES
  • TABLE 74. ALPHATEC HOLDINGS, INC: COMPANY SNAPSHOT
  • TABLE 75. ALPHATEC HOLDINGS, INC: OPERATING SEGMENTS
  • TABLE 76. ALPHATEC HOLDINGS, INC: PRODUCT PORTFOLIO
  • TABLE 77. ALPHATEC HOLDINGS, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. , B BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 79. , B BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 80. , B BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 81. , B BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 82. , B BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. EXACTECH, INC: KEY EXECUTIVES
  • TABLE 84. EXACTECH, INC: COMPANY SNAPSHOT
  • TABLE 85. EXACTECH, INC: OPERATING SEGMENTS
  • TABLE 86. EXACTECH, INC: PRODUCT PORTFOLIO
  • TABLE 87. EXACTECH, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. , JOHNSON AND JOHNSON (DEPUY SYNTHES),: KEY EXECUTIVES
  • TABLE 89. , JOHNSON AND JOHNSON (DEPUY SYNTHES),: COMPANY SNAPSHOT
  • TABLE 90. , JOHNSON AND JOHNSON (DEPUY SYNTHES),: OPERATING SEGMENTS
  • TABLE 91. , JOHNSON AND JOHNSON (DEPUY SYNTHES),: PRODUCT PORTFOLIO
  • TABLE 92. , JOHNSON AND JOHNSON (DEPUY SYNTHES),: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. GLOBUS MEDICAL, INC: KEY EXECUTIVES
  • TABLE 94. GLOBUS MEDICAL, INC: COMPANY SNAPSHOT
  • TABLE 95. GLOBUS MEDICAL, INC: OPERATING SEGMENTS
  • TABLE 96. GLOBUS MEDICAL, INC: PRODUCT PORTFOLIO
  • TABLE 97. GLOBUS MEDICAL, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. , MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 99. , MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 100. , MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 101. , MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 102. , MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. NUVASIVE, INC: KEY EXECUTIVES
  • TABLE 104. NUVASIVE, INC: COMPANY SNAPSHOT
  • TABLE 105. NUVASIVE, INC: OPERATING SEGMENTS
  • TABLE 106. NUVASIVE, INC: PRODUCT PORTFOLIO
  • TABLE 107. NUVASIVE, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. , ORTHOFIX INTERNATIONAL N.V: KEY EXECUTIVES
  • TABLE 109. , ORTHOFIX INTERNATIONAL N.V: COMPANY SNAPSHOT
  • TABLE 110. , ORTHOFIX INTERNATIONAL N.V: OPERATING SEGMENTS
  • TABLE 111. , ORTHOFIX INTERNATIONAL N.V: PRODUCT PORTFOLIO
  • TABLE 112. , ORTHOFIX INTERNATIONAL N.V: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. STRYKER CORPORATION,: KEY EXECUTIVES
  • TABLE 114. STRYKER CORPORATION,: COMPANY SNAPSHOT
  • TABLE 115. STRYKER CORPORATION,: OPERATING SEGMENTS
  • TABLE 116. STRYKER CORPORATION,: PRODUCT PORTFOLIO
  • TABLE 117. STRYKER CORPORATION,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. ZIMMER BIOMET HOLDINGS, INC: KEY EXECUTIVES
  • TABLE 119. ZIMMER BIOMET HOLDINGS, INC: COMPANY SNAPSHOT
  • TABLE 120. ZIMMER BIOMET HOLDINGS, INC: OPERATING SEGMENTS
  • TABLE 121. ZIMMER BIOMET HOLDINGS, INC: PRODUCT PORTFOLIO
  • TABLE 122. ZIMMER BIOMET HOLDINGS, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET
  • FIGURE 3. SEGMENTATION AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALAUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET
  • FIGURE 11. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET SEGMENTATION, BY PRODUCT TYPE
  • FIGURE 12. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET FOR SPINAL FUSION DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET FOR NON-FUSION/MOTION PRESERVATION DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET FOR VERTEBRAL COMPRESSION FRACTURE DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET FOR SPINE BONE STIMULATORS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET FOR SPINE BIOLOGICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET SEGMENTATION, BY SURGERY
  • FIGURE 18. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET FOR OPEN SPINE SURGERY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET FOR MINIMALLY INVASIVE SPINE SURGERY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: AUSTRALIA AND NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET
  • FIGURE 26. TOP PLAYER POSITIONING,2022
  • FIGURE 27. ALPHATEC HOLDINGS, INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 28. ALPHATEC HOLDINGS, INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 29. ALPHATEC HOLDINGS, INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 30. , B BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. , B BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. , B BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. EXACTECH, INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. EXACTECH, INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. EXACTECH, INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. , JOHNSON AND JOHNSON (DEPUY SYNTHES),: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. , JOHNSON AND JOHNSON (DEPUY SYNTHES),: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. , JOHNSON AND JOHNSON (DEPUY SYNTHES),: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. GLOBUS MEDICAL, INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. GLOBUS MEDICAL, INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. GLOBUS MEDICAL, INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. , MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. , MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. , MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. NUVASIVE, INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. NUVASIVE, INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. NUVASIVE, INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. , ORTHOFIX INTERNATIONAL N.V: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. , ORTHOFIX INTERNATIONAL N.V: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. , ORTHOFIX INTERNATIONAL N.V: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. STRYKER CORPORATION,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. STRYKER CORPORATION,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. STRYKER CORPORATION,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. ZIMMER BIOMET HOLDINGS, INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. ZIMMER BIOMET HOLDINGS, INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. ZIMMER BIOMET HOLDINGS, INC: REVENUE SHARE, BY REGION, 2032 (%)

Purchase Full Report of
Australia & New Zealand Spinal Implants and Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved